daunorubicin has been researched along with Mast-Cell Sarcoma in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Marshall, B; Ralph, RK | 1 |
| Guenther, PP; Huebner, A; Neumeister, V; Parwaresch, R; Sobottka, SB; Todt, H; Weissbach, G | 1 |
| Mihich, E; Orsini, F; Pavelic, Z | 1 |
3 other study(ies) available for daunorubicin and Mast-Cell Sarcoma
| Article | Year |
|---|---|
A simple method for detecting drug effects on the DNA of mammalian cells.
Topics: Aminacrine; Animals; Daunorubicin; DNA; Doxorubicin; Mast-Cell Sarcoma; Methods; Mice; Viscosity | 1982 |
Temporary response of localized intracranial mast cell sarcoma to combination chemotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Combined Modality Therapy; Cranial Irradiation; Cytarabine; Daunorubicin; Disease Progression; Etoposide; Fatal Outcome; Female; Headache; Humans; Immunologic Factors; Injections, Spinal; Interferon alpha-2; Interferon-alpha; Mast-Cell Sarcoma; Nausea; Neoplasm Recurrence, Local; Palliative Care; Papilledema; Parietal Lobe; Prednisolone; Radioisotope Teletherapy; Recombinant Proteins; Remission Induction; Supratentorial Neoplasms; Temporal Lobe; Treatment Failure; Vomiting | 2001 |
Increased primary cell-mediated immunity in culture subsequent to adriamycin or daunorubicin treatment of spleen donor mice.
Topics: Animals; Antigens, Neoplasm; Cell Adhesion; Cell Separation; Cells, Cultured; Cytotoxicity Tests, Immunologic; Daunorubicin; Doxorubicin; Epitopes; Immunity, Cellular; In Vitro Techniques; Leukemia L1210; Leukemia, Experimental; Macrophages; Mast-Cell Sarcoma; Mice; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred DBA; Neoplasms, Experimental; Spleen; Thymoma; Time Factors | 1977 |